about
Beyond D'Amico risk classes for predicting recurrence after external beam radiotherapy for prostate cancer: the Candiolo classifierPerfusion and thermal field during hyperthermia. Experimental measurements and modelling in recurrent breast cancer.External beam radiotherapy plus high-dose-rate brachytherapy for treatment of locally advanced prostate cancer: the initial experience of the Catalan Institute of Oncology.Laparotomy wound recurrence of endometrial carcinoma.Survey on gynecological cancer treatment by Piedmont, Liguria, and Valle d'Aosta group of AIRO (Italian Association of Radiation Oncology)Quality assurance of 3D-CRT: indications and difficulties in their applications.MET inhibition overcomes radiation resistance of glioblastoma stem-like cells.Accessibility as a major determinant of radiotherapy underutilization: a population based study.Induction of MET by ionizing radiation and its role in radioresistance and invasive growth of cancer.A pre-treatment quality assurance survey on 384 patients treated with helical intensity-modulated radiotherapy.Tomotherapy PET-guided dose escalation: A dosimetric feasibility study for patients with malignant pleural mesothelioma.Patterns of prescription and adherence to European Association of Urology guidelines on androgen deprivation therapy in prostate cancer: an Italian multicentre cross-sectional analysis from the Choosing Treatment for Prostate Cancer (CHOICE) study.Survival in patients with recurrent squamous cell head and neck carcinoma treated with bio-chemotherapy.Impact of the radiotherapy technique on the correlation between dose-volume histograms of the bladder wall defined on MRI imaging and dose-volume/surface histograms in prostate cancer patients.Prospective phase II trial of neoadjuvant chemo-radiotherapy with Oxaliplatin and Capecitabine in locally advanced rectal cancer (XELOXART).Docetaxel and vinorelbine: an effective regimen in recurrent squamous cell esophageal carcinoma.Salvage external beam radiotherapy for recurrent prostate adenocarcinoma after high-intensity focused ultrasound as primary treatment.Could machine learning improve the prediction of pelvic nodal status of prostate cancer patients? Preliminary results of a pilot study.Endorectal magnetic resonance imaging at 1.5 Tesla to assess local recurrence following radical prostatectomy using T2-weighted and contrast-enhanced imaging.Phase II trial of primary radiation therapy and concurrent chemotherapy for patients with locally advanced pancreatic cancer.Effects of fluconazole in the prophylaxis of oropharyngeal candidiasis in patients undergoing radiotherapy for head and neck tumour: results from a double-blind placebo-controlled trial.Does tumor growth follow a "universal law"?Erratum to: Tomotherapy PET-guided dose escalation--A dosimetric feasibility study for patients with malignant pleural mesothelioma.Accelerated partial breast irradiation using 3D conformal radiotherapy: toxicity and cosmetic outcome.Increasing the risk of late rectal bleeding after high-dose radiotherapy for prostate cancer: the case of previous abdominal surgery. Results from a prospective trial.Thermal response of contrast agent microbubbles: preliminary results from physico-chemical and US-imaging characterization.Pretreatment patient-specific IMRT quality assurance: a correlation study between gamma index and patient clinical dose volume histogram.Prostate image-guided radiotherapy by megavolt cone-beam CT.PC-aided assessment of the thermal performances of a MW applicator for oncological hyperthermia.Undifferentiated nasopharyngeal-type carcinoma in a nurse handling cytostatic agents.Emptying the rectum before treatment delivery limits the variations of rectal dose - volume parameters during 3DCRT of prostate cancer.Chondrosarcoma of the nasal septumIs It Time to Tailor the Prediction of Radio-Induced Toxicity in Prostate Cancer Patients? Building the First Set of Nomograms for Late Rectal SyndromeClinical and dosimetric predictors of late rectal toxicity after conformal radiation for localized prostate cancer: Results of a large multicenter observational studyQuality indicators in radiotherapyInduction gemcitabine and oxaliplatin therapy followed by a twice-weekly infusion of gemcitabine and concurrent external-beam radiation for neoadjuvant treatment of locally advanced pancreatic cancerRadio hyperthermia for re-treatment of superficial tumoursGrowth Laws in Cancer: Implications for RadiotherapyPancreatic Resections after Chemoradiotherapy for Locally Advanced Ductal Adenocarcinoma: Analysis of Perioperative Outcome and SurvivalAccelerated versus conventional fractionated postoperative radiotherapy for advanced head and neck cancer: Results of a multicenter Phase III study
P50
Q27301431-2347DB62-2CE1-49DC-A307-2D94ADCBA096Q31975928-B8FBC025-268B-4161-A7A9-CF509EC713F0Q33845994-4868F3C9-0B47-463E-98A1-A958EDA14B6DQ35576515-EC37D05A-FB42-4C63-9F68-E35E4AA34617Q36918472-7CF3E911-E13B-44EB-BA6E-8DD96D994CA2Q37259793-951F4B72-6255-467E-AE78-4E2DF761CE4BQ37458626-BDD32E1E-6508-42E6-80E4-8771B4500668Q38452710-895C9BDB-269C-4818-A06B-DCDDC23B2AD3Q39564618-9146CCF2-326C-4572-A9B1-32FFBC7E4D8EQ40096137-9AB55F73-5C36-4416-814C-906C3F8781EEQ41239654-A57D14DF-67CD-43CF-BD90-567712F28EC6Q41430910-D689AF49-C74A-4A05-8C66-69267C1DC579Q43635735-7B0920CD-9A95-4689-B4BF-B9DF481D382FQ43750117-82CDAF75-A501-4DBB-BA0A-625FBB8B32F4Q44197593-D8913F4E-7A5D-470E-8890-956DA57CC79AQ44383143-66D31946-9B42-49B4-A60E-E1E5FDC7AE44Q44384467-B40D4C10-04B4-49AF-BE1E-B49D1AF73455Q45954421-1E9CC836-C321-4CF1-98DF-45325CDA19F8Q46339990-553ED73E-AAA9-443F-86D8-4B5067730690Q46601912-F5F6E74C-04FE-47B9-9D03-87EC2BFAF552Q46639290-B51C549E-41E0-41FD-B9E1-54192D46DE93Q47426728-DB8F2CD4-15AE-4340-8E79-41F0C34B0B20Q47969651-4AB5762D-2323-443B-AF7A-813FF1C8D527Q48185188-9E040871-58FF-4C8B-8E59-77C29B34194CQ50151423-555E9E7C-6102-460F-90D8-CF6498762354Q51115436-21F6D41B-BC1E-4E29-85C8-D4B6650EED35Q51289013-C0E58CF5-C0E4-4760-BA99-8D1D70E9B750Q51545591-8519C685-452A-4518-BF75-A2227B19B118Q51719280-44BB0BD4-0F42-4B07-8547-298F371EFB60Q53481435-BCFBC8BB-B152-4083-8B40-E92639572801Q53521238-DEC251BD-35A0-4BA4-8BA7-AB31EEF21130Q57759098-97A21314-FFE3-45DE-92A0-735CCF996676Q59708583-B57797EF-41AC-4492-B6AB-2D1772C31EFFQ59708588-EB37261C-07D2-4828-882B-D5493976EA56Q61094975-A408B1F0-67CC-46A7-BD00-B65AB653CEE5Q62760400-2C2E14AF-1553-445D-8401-E5D7727B9552Q62760446-07B813A9-FA9C-4CEB-B388-D20F87D95BD8Q62760453-5169F3ED-D316-456C-A320-E56213F01C5BQ62760462-E4264734-8B52-47F4-8AFD-13FB8CE188D0Q62760466-2EEF5271-5F66-4A94-B711-98B247237D51
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Pietro Gabriele
@ast
Pietro Gabriele
@en
Pietro Gabriele
@es
Pietro Gabriele
@sl
type
label
Pietro Gabriele
@ast
Pietro Gabriele
@en
Pietro Gabriele
@es
Pietro Gabriele
@sl
prefLabel
Pietro Gabriele
@ast
Pietro Gabriele
@en
Pietro Gabriele
@es
Pietro Gabriele
@sl
P106
P1153
7006144692
P21
P31
P496
0000-0002-1792-2525